{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:32:29Z","timestamp":1791419549990,"version":"4.3.3"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Stockholm County Council-Karolinska Institute"},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007416","name":"Swedish Brain Power","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007416","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Magnus Bergvalls Foundation"},{"name":"Karolinska Institutet Foundations"},{"DOI":"10.13039\/100010815","name":"Foundation for Old Servants","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009673","name":"Gun and Bertil Stohnes Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Dementia Association (Demensfonden)"},{"name":"Alzheimer Foundation in Sweden"},{"name":"The Lars Hierta Memorial Foundation"},{"name":"Olle Engkvist Byggm\u00e4stare Foundation"},{"name":"Loo and Hans Osterman Foundation"},{"name":"Sigurd and Elsa Goljes Memorial Foundation"},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.neurobiolaging.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T21:32:29Z","timestamp":1308951149000},"page":"825.e1-825.e13","source":"Crossref","is-referenced-by-count":77,"title":["Different \u03b2-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity"],"prefix":"10.1016","volume":"33","author":[{"given":"Fuxiang","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn","family":"Wicklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale N.","family":"Lacor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Nordberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Marutle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00688184","article-title":"Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis","volume":"74","author":"Alafuzoff","year":"1987","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2010.04.031","article-title":"Probing the biology of Alzheimer's disease in mice","volume":"66","author":"Ashe","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","article-title":"Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease","volume":"95","author":"Barghorn","year":"2005","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib4","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1021\/bi030029q","article-title":"Self-assembly of Abeta(1\u201342) into globular neurotoxins","volume":"42","author":"Chromy","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib7","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.1975.tb11895.x","article-title":"A rapid radiochemical method for the determination of choline acetyltransferase","volume":"24","author":"Fonnum","year":"1975","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib9","first-page":"1633","article-title":"Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease","volume":"152","author":"Funato","year":"1998","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib10","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1074-5521(97)90255-6","article-title":"Observation of metastable Abeta amyloid protofibrils by atomic force microscopy","volume":"4","author":"Harper","year":"1997","journal-title":"Chem. Biol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archneurol.2009.46","article-title":"Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease","volume":"66","author":"Ikonomovic","year":"2009","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib17","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib18","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1529\/biophysj.107.110148","article-title":"Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process","volume":"93","author":"Jang","year":"2007","journal-title":"Biophys. J"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib19","article-title":"Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease","author":"Kadir","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-006-0447-7","article-title":"PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease","volume":"188","author":"Kadir","year":"2006","journal-title":"Psychopharmacol. Berl"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/brain\/awq349","article-title":"Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease","volume":"134","author":"Kadir","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJMcp022295","article-title":"Clinical practice","volume":"349","author":"Kawas","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib24","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","article-title":"Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques","volume":"106","author":"Koffie","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib25","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","article-title":"Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains","volume":"271","author":"Kuo","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib26","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib28","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.2006.04157.x","article-title":"Monoclonal antibodies that target pathological assemblies of Abeta","volume":"100","author":"Lambert","year":"2007","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1471-4159.2001.00592.x","article-title":"Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies","volume":"79","author":"Lambert","year":"2001","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Laur\u00e9n","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesn\u00e9","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-2010-101242","article-title":"Functional interactions of fibrillar and oligomeric amyloid-\u03b2 with alpha7 nicotinic receptors in Alzheimer's disease","volume":"23","author":"Lilja","year":"2011","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1523\/JNEUROSCI.3952-08.2009","article-title":"A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides","volume":"29","author":"Liu","year":"2009","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1471-4159.2000.0721161.x","article-title":"Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670\/671 mutation","volume":"72","author":"Marutle","year":"1999","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib37","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awq065","article-title":"The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia","volume":"133","author":"Mc Donald","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0891-0618(03)00068-1","article-title":"Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction","volume":"26","author":"Mufson","year":"2003","journal-title":"J. Chem. Neuroanat"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib40","first-page":"345","article-title":"A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Genet"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(04)00853-1","article-title":"PET imaging of amyloid in Alzheimer's disease","volume":"3","author":"Nordberg","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrneurol.2009.217","article-title":"The use of PET in Alzheimer disease","volume":"6","author":"Nordberg","year":"2010","journal-title":"Nat. Rev. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib43","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson's disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib44","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.1523\/JNEUROSCI.3537-10.2010","article-title":"Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils","volume":"30","author":"O'Nuallain","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog. Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/brain\/awp326","article-title":"Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden","volume":"133","author":"Rabinovici","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib48","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.0b013e3181bacf1b","article-title":"Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls","volume":"73","author":"Scheinin","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2009.07.021","article-title":"Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life","volume":"36","author":"Shankar","year":"2009","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib50","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib51","first-page":"597","article-title":"The amyloid beta ion channel hypothesis of Alzheimer's disease","volume":"3","author":"Shirwany","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat"},{"issue":"suppl 2","key":"10.1016\/j.neurobiolaging.2011.05.003_bib52","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/00002093-200607001-00010","article-title":"Cognitive reserve and Alzheimer disease","volume":"20","author":"Stern","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib53","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","article-title":"Cognitive reserve","volume":"47","author":"Stern","year":"2009","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib54","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1212\/WNL.55.9.1278","article-title":"The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease","volume":"55","author":"Tiraboschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cem.695","article-title":"Orthogonal projections to latent structures (O-PLS)","volume":"16","author":"Trygg","year":"2002","journal-title":"J. Chemom"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib56","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/ja9096303","article-title":"Elucidation of amyloid beta-protein oligomerization mechanisms: discrete molecular dynamics study","volume":"132","author":"Urbanc","year":"2010","journal-title":"J. Am. Chem. Soc"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib57","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib58","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"beta-Amyloid(1\u201342) binds to alpha7 nicotinic acetylcholine receptor with high affinity","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib59","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1523\/JNEUROSCI.6088-08.2009","article-title":"Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain","volume":"29","author":"Wang","year":"2009","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0169-7439(01)00156-3","article-title":"Some recent developments in PLS modeling","volume":"58","author":"Wold","year":"2001","journal-title":"Chemom. Intell. Lab. Syst"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2011.05.003_bib62","doi-asserted-by":"crossref","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","article-title":"Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}","volume":"284","author":"Zhao","year":"2009","journal-title":"J. Biol. Chem"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458011001709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458011001709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T23:17:14Z","timestamp":1588807034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458011001709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0197458011001709"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.05.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}